Dr. Mohamed is a Psychiatrist Neuroscientist. He earned his medical degree from Menoufia Medical School, Egypt and his research doctorate degree from the Penn State University, USA. Currently, he is an assistant professor in IIUM, Malaysia. He has published widely in the field of Parkinson as well as Alzheimer’s Dementia, with about 120 peer-reviewed journal papers with >800 citations, h-index 32. He authored for Springer, Cambridge, and Elsevier. He is the founder and president of AfrAbia Society (AAS). He has delivered and/or participated in >200 international-level lectures and expert panels. He received many research grants from national and international organizations namely IBRO, ISN, MJF, STDF, FRGS, and INDO-ASEAN with a total research funding of One million US$. He is now an active partner in GP2 consortium (IPDG-Asia). Dr. Firas Kobeissy is an Associate Professor at the American University of Beirut in the Biochemistry and Molecular Genetics department. Dr. Kobeissy obtained his Ph.D. from the University of Florida in the area of Neuroscience with a focus on brain injury biomarkers. He is a trained neuroscientist with extensive expertise in neurotrauma and drug abuse research utilizing neuroproteomics approaches. His research interest is focused on applications of proteomics related to brain injury models, including closed head injuries and blast injuries. Dr. Kobeissy has authored more than 240 articles, reviews, and book chapters along with two patents. He is the associate director of the Center of Neuroproteomics and Biomarker Research (NNBR) at the McKnight Brain Institute at the University of Florida, Department of Emergency Medicine. He is the current president of the International Brain Research Organization- MENA chapter (2020-2023). He serves as the current president of the International Brain Research Organization (IBRO) MENA Chapter (2020-2023).
